Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Gossamer Bio, Inc. (GOSS) had Stock-Based Compensation of $20.62M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$114.70M |
|
$-56.53M |
|
-- |
|
$114.70M |
|
$174.62M |
|
$-59.92M |
|
$4.28M |
|
$-55.63M |
|
$-55.63M |
|
$-56.53M |
|
$-56.53M |
|
$-56.53M |
|
$-56.53M |
|
$-59.92M |
|
$-67.74M |
|
226.23M |
|
226.23M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$309.89M |
|
$0.01M |
|
$5.40M |
|
$315.29M |
|
$45.01M |
|
$197.52M |
|
$240.79M |
|
$285.80M |
|
$29.49M |
|
$29.49M |
|
$29.49M |
|
226.60M |
|
| Cash Flow Statement Financials | |
$-3.47M |
|
$29.02M |
|
$-11.49M |
|
$32.11M |
|
$46.07M |
|
$13.96M |
|
|
Stock-Based Compensation |
$20.62M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.88 |
|
-- |
|
-- |
|
0.87 |
|
6.70 |
|
100.00% |
|
-52.24% |
|
-52.24% |
|
-59.06% |
|
-48.50% |
|
-49.28% |
|
$-3.47M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
-- |
|
21.49 |
|
16.99 |
|
-191.67% |
|
-191.67% |
|
-17.93% |
|
-24.90% |
|
$0.13 |
|
$-0.02 |
|
$-0.02 |
|